Association of serum interleukin-6, interleukin-8, and Acute Physiology and Chronic Health Evaluation II score with clinical outcome in patients with acute respiratory distress syndrome
Open Access
- 1 September 2016
- journal article
- research article
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 20 (9) , 518-525
Abstract
Background and Aim: Studies on potential biomarkers in experimental models of acute lung injury (ALI) and clinical samples from patients with ALI have provided evidence to the pathophysiology of the mechanisms of lung injury and predictor of clinical outcome. Because of the high mortality and substantial variability in outcomes in patients with acute respiratory distress syndrome (ARDS), identification of biomarkers such as cytokines is important to determine prognosis and guide clinical decision-making. Materials and Methods: In this study, we have included thirty patients admitted to Intensive Care Unit diagnosed with ARDS, and serum samples were collected on day 1 and 7 and were analyzed for serum interleukin-6 (IL-6) and IL-8 by ELISA method, and Acute Physiology and Chronic Health Evaluation II (APACHE II) scoring was done on day 1. Results: The mortality in the patients observed with ARDS was 34%. APACHE II score was significantly higher in nonsurvivors as compared to survivors. There were no significant differences in gender and biochemical and hematological parameters among the survivors and nonsurvivors. Serum IL-6 and IL-8 levels on day 1 were significantly higher in all the ARDS patients as compared to healthy controls and these levels were returned to near-normal basal levels on day 7. The serum IL-6 and IL-8 levels measured on day 7 were of survivors. As compared to survivors, the IL-6 and IL-8 levels were significantly higher in nonsurvivors measured on day 1. Spearman's rank correlation analysis indicated a significant positive correlation of APACHE II with IL-8. By using APACHE II score, IL-6, and IL-8, the receiver operating characteristic curve was plotted and the provided predictable accuracy of mortality (outcome) was 94%. Conclusion: The present study highlighted the importance of measuring the cytokines such as IL-6 and IL-8 in patients with ARDS in predicting the clinical outcome.Keywords
This publication has 33 references indexed in Scilit:
- Biomarkers of lung epithelial injury and inflammation distinguish severe sepsis patients with acute respiratory distress syndromeCritical Care, 2013
- Acute respiratory distress syndrome: epidemiology and management approachesClinical Epidemiology, 2012
- Intraoperative Risk Factors for Acute Respiratory Distress Syndrome in Critically Ill PatientsAnesthesia & Analgesia, 2010
- Acute Lung Injury in Patients With Traumatic Injuries: Utility of a Panel of Biomarkers for Diagnosis and PathogenesisJournal of Trauma: Injury, Infection & Critical Care, 2010
- Prognostic and Pathogenetic Value of Combining Clinical and Biochemical Indices in Patients With Acute Lung InjuryChest, 2010
- Lower incidence of acute respiratory distress syndrome in community‐acquired pneumonia patients aged 85 years or olderRespirology, 2010
- Monocyte Chemoattractant Protein-1 (MCP-1): An OverviewJournal of Interferon & Cytokine Research, 2009
- Incidence and Outcomes of Acute Lung InjuryNew England Journal of Medicine, 2005
- Incidence, clinical course, and outcome in 217 patients with acute respiratory distress syndromeCritical Care Medicine, 2002
- Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedemaEuropean Respiratory Journal, 1996